Biological Mechanisms and Therapeutic Potential of Molecular Hydrogen

• Utgivningsdatum: 2027-04-09
• Mått: 178 x 254 x undefined mm
• Format: Inbunden
• Språk: Engelska
• Antal sidor: 232
• Förlag: Taylor & Francis Ltd
• ISBN: 9781041090328

• Hjärt- och kärlsjukdomar
• Farmakologi
• Neurologi och klinisk neurofysiologi
• Biologi

Rahima Begum is a researcher in Medical Science, Cellular and Molecular Biology, Microbiology, and Immunology, with a strong focus on health and disease. She earned her Ph.D. from Yonsei University, South Korea, and currently serves as an Assistant Professor in the Department of Microbiology at Gono Bishwabidyalay, Dhaka, Bangladesh. Her research interests encompass molecular mechanisms underlying health and disease, with particular emphasis on molecular hydrogen and its therapeutic potential, as well as the antioxidant and antibacterial properties of medicinal plants and plant-derived extracts. Her research also explores the potential application of natural bioactive compounds in combating oxidative stress, microbial infections, inflammation, and other disease-associated conditions. Dr. Rahima is passionate about interdisciplinary and collaborative research and is committed to developing innovative approaches to address emerging challenges in biomedical and health sciences. She applies her expertise in microbiology, molecular biology, immunology, and experimental research to investigate scientifically and clinically relevant problems. She is adaptable, detail-oriented, proactive, and capable of working effectively both independently and as part of multidisciplinary research teams. Her work is dedicated to advancing biomedical knowledge and contributing to improved health outcomes through innovative, evidence-based research.Md. Habibur Rahman is an internationally recognized medical scientist, registered pharmacist, and translational neuroscience researcher with multidisciplinary expertise spanning neuroscience, neuropharmacology, molecular biology, oxidative stress, neuroinflammation, biomarker discovery, and therapeutic development. He holds a Ph.D. in Medical Science and has established a strong research profile at the interface of molecular mechanisms, disease biology, pharmacological intervention, and clinical translation, with his primary research focused on dementia and neurodegenerative diseases, particularly Alzheimer’s disease, and the discovery of clinically relevant biomarkers, molecular targets, and precision diagnostic and therapeutic strategies. His extensive expertise encompasses gene-expression analysis, redox biology, neuroinflammatory signaling, molecular and cellular mechanisms of neurodegeneration, experimental pharmacology, and translational therapeutics, enabling him to bridge fundamental biomedical discoveries with clinically meaningful innovations. Dr. Rahman has received international recognition, including being ranked among the top 2% of scientists worldwide in Stanford University’s citation-based global ranking, reflecting the impact and international visibility of his scientific contributions. He is an active scientific leader, invited speaker, peer reviewer, and international collaborator, regularly contributing to global conferences, academic forums, multidisciplinary research initiatives, and the peer-review process for international scientific journals. His long-term research vision is to advance precision medicine in neurological disease through innovative biomarker discovery, therapeutic target identification, and the translation of molecular neuroscience into clinically actionable diagnostic and treatment strategies.Athanasios Alexiou has a BSc in Applied Mathematics from the National and Kapodistrian University of Athens, a Ph.D. in Bioinformatics Algorithms and Mathematical Modeling in Biology, and a two-year Postdoc Research Fellowship in Neuroinformatics Applications from the Ionian University. Dr. Alexiou is a Class-IV Member of the European Academy of Sciences and Arts (Austria) and a Fellow at the Institute of Biomedical Science (UK). He is highly ranked in computational biomedicine. Notably, Dr. Alexiou has been listed among the top 2% of the world’s most-cited researchers, according to the Stanford University 2025 annual ranking. He is the Medical Director of Nexus Medical Technologies in Greece (representing NeXus Neurofeedback and Biofeedback devices from the Mind Media Europe Group and the PBM Helmets from the MyBrainMap International), Head of Research and Education at Funogen Research Company in Greece and an Adjunct Professor at the University Centre for Research and Development at Chandigarh University in India. Dr. Alexiou's area of research is Computational Biomedicine with a special interest in developing novel mathematical models and algorithms in neurodegenerative diseases, Bayesian prognostic tools, and the application of artificial intelligence and machine learning methods. He has also made significant contributions to the study of molecular mechanisms in infectious diseases, cancer biomarkers, the impact of nanotoxicity of biotechnology applications on human health, and the ethical implications of scientific research. He has authored over 400 peer-reviewed publications and edited books. Dr. Alexiou serves as an Associate Editor for prestigious journals, participates in international research projects, and has over 25 years of mentoring experience.Muhasina K.M. is a distinguished researcher and academician in pharmaceutical sciences, specialising in cancer biology, herbal formulations, gut-microbiome interactions, and multidrug-resistant cancers. She earned her PhD from JSS College of Pharmacy, Ooty, and works as an associate professor and research coordinator at Prime College of Pharmacy, affiliated with Kerala University of Health Sciences. Her research investigates the molecular mechanisms of phytochemicals in targeting triple-negative breast cancer and the role of gut microbiota in disease progression. With expertise in advanced analytical techniques, Dr. Muhasina has authored numerous high-impact publications, edited several academic textbooks with international publishers including Springer Nature and IGI Global Scientific Publishing, and secured multiple patents on herbal drug formulations and AI-based pharmaceutical technologies. Recognized with prestigious awards, she is committed to advancing cancer therapeutics by developing novel plant-based interventions. Her research is widely acknowledged in national and international forums, where she has delivered award-winning presentations and invited lectures.S.P. Dhanabal is a distinguished professor and principal at JSS College of Pharmacy, Ooty, with over 35 years of experience in teaching and research. His expertise includes herbal drug research, bioactive compound isolation, and the development of herbal formulations for therapeutic applications. Dr. Dhanabal has mentored several international researchers and has delivered invited lectures at prestigious institutions worldwide. He has collaborated with universities in Australia, Singapore, Malaysia, Belgium, Canada, and the UK, contributing to international projects, including those funded by Pukka Herbs, UK. Dr Dhanabal is a distinguished researcher in neuropharmacology, obesity, cardiometabolic health, and molecular docking. He has also provided consultancy services to leading pharmaceutical industries and regulatory bodies, including the Indian and United States Pharmacopoeia, Natural Remedies, and Spices Board of India. His global engagements highlight his dedication to advancing herbal medicine research and standardisation.

0 recensioner

Inga recensioner tillgängliga.